Literature DB >> 25162951

Fictitious hyperglycemia: point-of-care glucose measurement is inaccurate during high-dose vitamin C infusion for burn shock resuscitation.

Steven A Kahn1, Christopher W Lentz.   

Abstract

The use of high-dose vitamin C (hdVC, 66 mg/kg/hour × 18 hours) infusion is a useful adjunct to reducing fluid requirements during resuscitation of burn shock. Routine point-of-care glucose (POCG) analysis has been inaccurately high in observed patients undergoing hdVC. Inaccurate POCG could potentially lead to iatrogenic hypoglycemia if the fictitious hyperglycemia is treated with insulin. This study is a retrospective analysis of plasma glucose measurements from a central laboratory (LG) compared with POCG during and 24 hours after hdVC infusion. Records of adult patients receiving hdVC infusions during burn resuscitation over 1 year were reviewed. Charts selected for analysis included those with glucose measurements using POCG and LG that were taken simultaneously, during hdVC infusion, and 24 hours after completion. All specimens were drawn from arterial lines. POCG was measured with Accu-Chek Inform (Roche, Indianapolis, IN) and LG was measured by Siemens Dimension Vista 500 (Siemens, Deerfield, IL) using biochromic analysis. Nonparametric statistical analysis was performed using Wilcoxon's matched pairs test and Spearman correlation with significance at P < .05. Of 18 adult patients undergoing burn resuscitation with hdVC infusion, 5 were chosen for analysis (%TBSA 40 ± 15; age 51 ± 18). All data were pooled with 11 comparisons both during and after hdVC. The mean POCG (225 ± 71) was significantly higher than mean LG (138 ± 41) on hdVC (P = .002). There was no difference between POCG (138 ± 30) and LG (128 ± 23) after hdVC was finished (P = .09). There was a negative correlation between POCG and LG on hdVC (-0.64, P = .04) and a positive correlation off hdVC (0.89, P = .0005). POCG analysis during hdVC infusion is significantly higher than laboratory glucose measurements. Once the hdVC infusion is complete, POCG and laboratory glucose measurements are not statistically different. Treating erroneously high glucose based on POC testing is potentially dangerous and could lead to hypoglycemia and seizures.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25162951     DOI: 10.1097/BCR.0000000000000141

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  9 in total

1.  Impact of High-Dose Intravenous Vitamin C for Treatment of Sepsis on Point-of-Care Blood Glucose Readings.

Authors:  Anna Peyton Howell; Jenna L Parrett; Daniel R Malcom
Journal:  J Diabetes Sci Technol       Date:  2019-11-25

2.  High-dose vitamin-C induced prolonged factitious hyperglycemia in a peritoneal dialysis patient: a case report.

Authors:  Olivier Lachance; François Goyer; Neill K J Adhikari; Marie-Hélène Masse; Jean-François Bilodeau; François Lamontagne; Marc-André Leclair
Journal:  J Med Case Rep       Date:  2021-05-21

3.  Oxalate Nephropathy After Continuous Infusion of High-Dose Vitamin C as an Adjunct to Burn Resuscitation.

Authors:  Michelle Buehner; Jeremy Pamplin; Lynette Studer; Rhome L Hughes; Booker T King; John C Graybill; Kevin K Chung
Journal:  J Burn Care Res       Date:  2016 Jul-Aug       Impact factor: 1.845

4.  Never a rose without a prick: pseudohyperglycemia when administering high-dose intravenous vitamin C.

Authors:  Yongli Zhang; Wei Huang
Journal:  Crit Care       Date:  2020-05-24       Impact factor: 9.097

Review 5.  Intravenous Vitamin C for Cancer Therapy - Identifying the Current Gaps in Our Knowledge.

Authors:  Anitra C Carr; John Cook
Journal:  Front Physiol       Date:  2018-08-23       Impact factor: 4.566

6.  Iatrogenic severe hyperglycemia due to parenteral administration of glucose in children - a case series.

Authors:  Nora Bruns; Anja Große Lordemann; Tobias Rasche; Jochen Meyburg; Marcus Krüger; Christian Wieg; Alexander Gratopp; Marc Hoppenz; Friedhelm Heitmann; Thomas Hoppen; Günther Löffler; Ursula Felderhoff-Müser; Christian Dohna-Schwake
Journal:  Ital J Pediatr       Date:  2020-12-01       Impact factor: 2.638

7.  Lessening Organ Dysfunction With Vitamin C (LOVIT) Trial: Statistical Analysis Plan.

Authors:  Neill Kj Adhikari; François Lamontagne; Ruxandra Pinto; Andrew G Day; Marie-Hélène Masse; Julie Ménard; Sheila Sprague; Djillali Annane; Yaseen M Arabi; Marie-Claude Battista; Dian Cohen; Deborah J Cook; Gordon H Guyatt; Daren K Heyland; Salmaan Kanji; Shay P McGuinness; Rachael L Parke; Bharath Kumar Tirupakuzhi Vijayaraghavan; Emmanuel Charbonney; Michaël Chassé; Lorenzo Del Sorbo; Demetrios James Kutsogiannis; François Lauzier; Rémi Leblanc; David M Maslove; Sangeeta Mehta; Armand Mekontso Dessap; Tina S Mele; Bram Rochwerg; Oleksa G Rewa; Jason Shahin; Pawel Twardowski; Paul Jeffrey Young
Journal:  JMIR Res Protoc       Date:  2022-05-20

8.  Early administration of hydrocortisone, vitamin C, and thiamine in adult patients with septic shock: a randomized controlled clinical trial.

Authors:  Qing-Quan Lyu; Rui-Qiang Zheng; Qi-Hong Chen; Jiang-Quan Yu; Jun Shao; Xiao-Hua Gu
Journal:  Crit Care       Date:  2022-09-28       Impact factor: 19.334

Review 9.  Burns: Pathophysiology of Systemic Complications and Current Management.

Authors:  Colton B Nielson; Nicholas C Duethman; James M Howard; Michael Moncure; John G Wood
Journal:  J Burn Care Res       Date:  2017 Jan/Feb       Impact factor: 1.845

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.